Detail
LncRNA Name | NKILA |
Synonyms | AK056098 |
Region | GRCh38_20:57710183-57712780 Sequence |
Ensembl | ENSG00000278709 |
RefSeq | NR_131157 |
Circulating | ✘ |
Drug-resisitant | ✘ |
Prognostic | ✘ |
MiRNA | ✘ |
Variant | ✘ |
TF | ✔ |
Methylation | ✘ |
Cancer Name | malignant melanoma |
ICD-0-3 | M8720/3 |
Methods | qPCR, RNAi, Western blot, Flow cytometry assay, Cell proliferation assay etc. |
Sample | melanoma tissues, cell lines (M21, B16, MEL-RM, MM200, A375 and A2058) |
Expression Pattern | down-regulated |
Function Description | NKILA was expressed at low levels in human melanoma tissues. Our results also indicated that NKILA inhibited the progression of cell proliferation, migration, and invasion, and promoted apoptosis of melanoma cells. Furthermore, qRT-PCR showed that NF-kB, which was negatively correlated with NKILA, was highly expressed in human melanoma tissues. Moreover, our results indicated that NKILA inhibited the carcinogenesis of melanoma cells through the inhibition of NF-B in vitro. More importantly, we found that NKILA suppressed the growth of melanoma tumors via NF-B in vivo. |
Pubmed ID | 28123845 |
Year | 2017 |
Title | The long non-coding RNA NKILA inhibits the invasion-metastasis cascade of malignant melanoma via the regulation of NF-B. |
External Links |
Links for NKILA | GenBank HGNC lncrnadb Noncode |
Links for malignant melanoma | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.